Financial News
Update: Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)
October 21, 2024 at 14:00 PM EDT
DALLAS - 
(NewMediaWire) - October 21, 2024 - Sirona Biochem Corp: Stonegate Capital Partners initiates their coverage on Sirona Biochem Corp (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF).
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- GlycoProteMim™ is a potential standout in the premium skincare market
- Sirona is targeting profitability by 2025, with expected revenue from Allergan Aesthetic and the commercialization of GlycoProteMim™ set to drive growth.
- Sirona’s partnerships place it in a strong position to capture market share in the growing global skincare industry.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
